pharma · Severe Obesity · UPC
Universe Pharmaceuticals
Universe Pharmaceuticals INC
Universe Pharmaceuticals patent portfolio — 5 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Silverwater, AU
- Founded
- 1995
- Employees
- 56
- Programs
- 1
- Drugs
- 1
- Patents
- 5
Universe Pharmaceuticals patents
5 pharmaceutical patents indexed for Universe Pharmaceuticals. 0 expire within 24 months.
Universe Pharmaceuticals has 5 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12257132
Hydrogen-delivering system for a bodily orifice
granted -
US 12017030
Hydrogen-enhanced transdermal system
granted -
US 11364261
Alleviating common cold and influenza symptoms with molecular hydrogen
granted -
US 6319691
Fusion proteins comprising IFN-alpha2b and TM-alpha1
expired -
US 6204360
Retro-inverso thymosin alpha 1 hybrids
expired
Frequently asked questions
How many patents does Universe Pharmaceuticals have?
5 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Universe Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.